Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains

Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains

While individuals infected with coronavirus disease 2019 (COVID-19) manifested a broad range in susceptibility and severity to the disease, the pre-existing immune memory to related pathogens cross-reactive against SARS-CoV-2 can influence the disease outcome in COVID-19. Here, we investigated the p...

Full description

Bibliographic Details
Main Authors:	Lee, CH, Pinho, MP, Buckley, PR, Woodhouse, IB, Ogg, G, Simmons, A, Napolitani, G, Koohy, H
Format:	Journal article
Language:	English
Published:	Frontiers Media 2020

Similar Items

Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains
by: Chloe H. Lee, et al.
Published: (2020-11-01)

Predicting cross-reactivity and antigen specificity of T cell receptors
by: Lee, CH, et al.
Published: (2020)

Predicting Cross-Reactivity and Antigen Specificity of T Cell Receptors
by: Chloe H. Lee, et al.
Published: (2020-10-01)

Identification of Novel Candidate CD8<sup>+</sup> T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses
by: Pradeep Darshana Pushpakumara, et al.
Published: (2021-05-01)

Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
by: Eriko Padron-Regalado
Published: (2020-04-01)

A robust deep learning workflow to predict CD8 + T-cell epitopes
by: Chloe H. Lee, et al.
Published: (2023-09-01)

Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarray
by: Rafael Assis, et al.
Published: (2021-04-01)

Coronavirus replicase epitopes induce cross-reactive CD8 T cell responses in SARS-CoV-2-naive people with HIV-1
by: Katja G. Schmidt, et al.
Published: (2025-03-01)

SARS-CoV-2 and Other Coronaviruses in Rats, Berlin, Germany, 2023
by: Kerstin Wernike, et al.
Published: (2024-10-01)

Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
by: Jay, C
Published: (2023)

Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
by: Aniuska Becerra-Artiles, et al.
Published: (2023-07-01)

SARS-CoV-2 and other Coronaviruses: A matter of variations
by: Ibtesam Ghadban Auda, et al.
Published: (2023-04-01)

Structural Genomic Analysis of SARS-CoV-2 and Other Coronaviruses
by: Qiong Zhang, et al.
Published: (2022-04-01)

Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses
by: Gussow, Ayal B., et al.
Published: (2020)

Molecular insights on the coronavirus MERS-CoV interaction with the CD26 receptor
by: Hila Failayev, et al.
Published: (2024-04-01)

Elevated and cross‐responsive CD1a‐reactive T cells in bee and wasp venom allergic individuals
by: Subramaniam, S, et al.
Published: (2015)

Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses
by: M. Khalid Ijaz, et al.
Published: (2021-03-01)

Single-cell atlas of colonic CD8+ T cells in ulcerative colitis
by: Corridoni, D, et al.
Published: (2020)

Surveillance of Rodent Pests for SARS-CoV-2 and Other Coronaviruses, Hong Kong
by: Elliott F. Miot, et al.
Published: (2022-02-01)

Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses
by: P. Simmonds
Published: (2020-12-01)

Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France
by: Philippe Colson, et al.
Published: (2020-12-01)

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
by: Yang Yang, et al.
Published: (2024-05-01)

Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses
by: H.T. Lim, et al.
Published: (2022-12-01)

The Omicron Strain of the SARS-CoV-2 Coronavirus and Its Variants
by: Sergey G. Sсherbak, et al.
Published: (2023-10-01)

T-cell immunotherapy of allergic disease: the role of CD8+ T cells.
by: Ogg, G
Published: (2003)

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses
by: Katja G. Schmidt, et al.
Published: (2021-04-01)

HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes
by: Karnaukhov, V, et al.
Published: (2022)

To what extent does MHC binding translate to immunogenicity in humans?
by: Chloe H. Lee, et al.
Published: (2021-12-01)

Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles
by: Aniuska Becerra-Artiles, et al.
Published: (2022-06-01)

Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
by: Patrick O’Connell, et al.
Published: (2020-12-01)

Author Correction: Immunoreactive peptide maps of SARS-CoV-2 and other human coronaviruses
by: Nischay Mishra, et al.
Published: (2021-03-01)

Cross-reactivity and inclusivity analysis of CRISPR-based diagnostic assays of coronavirus SARS-CoV-2
by: Kashif Aziz Khan, et al.
Published: (2021-10-01)

Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses
by: Zhongren Ma, et al.
Published: (2020-08-01)

Quantitation of antigen-specific CD8+ T-cell responses.
by: Ogg, G, et al.
Published: (1999)

High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients
by: Pierre-Gregoire Coulon, et al.
Published: (2024-03-01)

Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.
by: Resmi Ravindran, et al.
Published: (2021-01-01)

Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
by: Nicola Borbone, et al.
Published: (2021-02-01)

Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses
by: Zhewei Shen, et al.
Published: (2022-11-01)

Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses
by: Marni E. Cueno, et al.
Published: (2021-01-01)

Virucidal efficacy of laundry sanitizers against SARS-CoV-2 and other coronaviruses and influenza viruses
by: M. Khalid Ijaz, et al.
Published: (2022-03-01)